pharmaphorum

MAY 30, 2022

Josh Sackman, president and co-founder of AppliedVR, and Web Sun, president and co-founder of Komodo Health, relay how their newly formed collaboration reshapes the clinical trial process by using data, helping to cut costs and allowing for evaluation of broader patient populations. . Distinct offerings.

Clinical Trials 88

Clinical Trials Clinical Trials Trials Big Data 88

pharmaphorum

FEBRUARY 1, 2022

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford.

Clinical Trials 94

Clinical Trials Clinical Trials Trials Engineer 94

Pharmaceutical Technology

MARCH 6, 2023

Incannex Healthcare has collaborated with New Jersey-based pharma company Catalent for the development and manufacturing of a cGMP-grade psilocybin drug product for clinical trials and potential commercial use. Catalent will develop the formulation and produce the required data for regulatory filings.

Manufacturing 264

Manufacturing Clinical Trials Clinical Trials Production 264

Drug Discovery World

OCTOBER 18, 2022

A working group has been created to measure and compare the carbon footprint of centralised (traditional site-based) and decentralised clinical trials. The Clinical Trials Environmental Impact Community of Interest (CoI) was started by Pistoia Alliance member, Syneos Health. Growing pressure on life sciences.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Life Science 52

XTalks

MAY 11, 2023

Clinical trials are essential for the development of new treatments for rare diseases, but they can be complex and challenging to execute. That mission is really important to me because I think it’s the only way we’re going to accelerate drug development in rare disease.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Development 97

XTalks

MAY 6, 2022

In this interview, Xtalks spoke with experts from eClinical Solutions , Katrina Rice, Chief Delivery Officer, Data Services; and Diane Lacroix, Vice President, Clinical Data Management, about clinical data management for modern day digital clinical trials. In addition, 43.4 percent were using or piloting omics data.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Life Science 98

pharmaphorum

FEBRUARY 11, 2021

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.

Clinical Trials 90

Clinical Trials Clinical Trials Trials Clinical Research 90

Pharmaceutical Technology

JUNE 15, 2023

AI for drug development is rapidly streamlining R&D processes, speeding up time to market and providing a better experience for patients and providers. Learn more about the role of AI in drug development and how healthcare researchers are using it to shake up the field.

Development 130

Development Drugs Clinical Trials Clinical Trials 130

The Pharma Data

DECEMBER 20, 2020

UK drug developer Scancell said it has chosen a COVID-19 vaccine candidate, SN14, from more than a dozen potential products to advance to a clinical trial. . SN14 works by targeting the coronavirus’ nucleocapsid and spike proteins to prevent viral replication using the company’s ImmunoBody DNA vaccine technology.

Clinical Trials 52

Clinical Trials Clinical Trials Pharma Companies Vaccination 52

AuroBlog - Aurous Healthcare Clinical Trials blog

APRIL 11, 2023

The pharma companies’ thrust on R&D to develop better medicines and the demand in hospitals for advanced medical technologies driven by artificial intelligence, remote patient monitoring and wearables are transforming patient care.

Medicine 145

Medicine Development Pharma Companies Clinical Trials 145

pharmaphorum

JANUARY 17, 2022

The adoption of decentralised activities was a major factor in allowing clinical trials to continue during the early stages of the pandemic. Ben Hargreaves examines whether this adoption looks set to become a permanent feature of clinical trials moving into the future, rather than just supplying the tools to a temporary need.

Trials 104

Trials Clinical Trials Clinical Trials Clinical Research 104

Intouch Solutions

OCTOBER 13, 2023

They can include the conditions in which people are born, live, learn, work, play, worship, and age 1,2 — as well as factors like economic policies and systems, development agendas, social norms, social policies and political systems. Pharmaceutical companies can develop and disperse these materials.

Pharma Companies 105

Pharma Companies Clinical Trials Clinical Trials Genetics 105

Outsourcing Pharma

NOVEMBER 15, 2021

The pharma company has completed enrollment of amyotrophic lateral sclerosis patients in its study investigating drugs like verdiperstat, an oral treatment.

Clinical Trials 69

Clinical Trials Clinical Trials Pharma Companies Trials 69

Pharmaceutical Technology

JANUARY 16, 2023

Moreover, Insilico Medicine’s INS018_055, an AI-designed candidate, has produced positive topline results in its Phase I clinical trial for idiopathic pulmonary fibrosis (IPF) treatment. In addition to collaborating with AI-technology providers, pharma companies are also engaging in vertical integration.

Big Data 303

Big Data Pharma Companies Clinical Trials Clinical Trials 303

Pharmaceutical Technology

APRIL 13, 2023

The company is aiming to refocus its efforts on its core therapeutic areas and current late-stage programmes such as the oral TYK2 inhibitor TAK-279, which is under development for several autoimmune disorders.

Gene Therapy 243

Gene Therapy Marketing Gene In-Vivo 243

pharmaphorum

JANUARY 24, 2022

The UK scientists that ran one of the largest trials of experimental COVID-19 drugs have formed a non-profit company that will apply the methodology to other disease areas – with $6.8 ” Those trials also need to be large, involve a diverse range of individuals, and able to be run at reduced cost, said Landray. .

Trials 86

Trials Drugs Clinical Trials Clinical Trials 86

The Pharma Data

OCTOBER 16, 2020

As pharma companies search for solutions to avoid cancelling or delaying clinical trials, virtualizing trials are fast becoming commonplace during the Covid-19 pandemic. BetterLife conducts patient centric study via a fully remote clinical trial.

In-Vitro 52

In-Vitro Clinical Trials Clinical Trials Trials 52

pharmaphorum

FEBRUARY 4, 2022

Last year, Bayer launched a project to explore the use of artificial intelligence in clinical trials, working with Finland’s Aalto University to find ways to use the technology to support decentralised trials and streamline the testing process.

Trials 68

Trials Clinical Trials Clinical Trials Pharma Companies 68

World of DTC Marketing

JANUARY 11, 2022

As HCPs get more digitally savvy, pharma marketers should understand that engaging physicians through channels and time of their preference with content relevant to the individual customer. Key findings: 77% of HCPs use digital channels primarily for personal learning and development.

Pharma Companies 235

Pharma Companies Sales Marketing Clinical Trials 235

Camargo

NOVEMBER 11, 2020

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Still, navigating such patent issues during drug development can be difficult, and Camargo can assist in finding a safe course. Ken Phelps.

Development 242

Development Bioequivalency Generic Drugs Production 242

Pharmaceutical Technology

FEBRUARY 24, 2023

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact.

Regulation 162

Regulation Clinical Trials Clinical Trials Medicine 162

Drug Discovery World

DECEMBER 12, 2022

Biometrics contract research organisation (CRO) Phastar has joined Lean Life Science’s Oncology Development Programme (ODP2). . The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies. .

Development 52

Development Drugs Pharma Companies Clinical Trials 52

pharmaphorum

JANUARY 14, 2021

Healthcare technology firm Seqster has introduced a new version of its service that aims to help pharma companies work with patients’ data while on virtual clinical trials. What Seqster does for pharma clinical trials is it brings together in real time a health record for participants.

Trials 52

Trials Clinical Trials Clinical Trials Pharma Companies 52

XTalks

FEBRUARY 21, 2024

Recently, Eli Lilly revealed promising results from a mid-stage trial, indicating that its popular drug, tirzepatide (marketed as Zepbound and Mounjaro for weight loss and diabetes, respectively), may be an effective treatment for the fatty liver disease metabolic dysfunction-associated steatohepatitis (MASH).

Clinical Trials 59

Clinical Trials Clinical Trials Trials Insulin 59

pharmaphorum

APRIL 22, 2021

Biosensor firm physIQ has licensed its technology to Johnson & Johnson’s Janssen pharma unit in a multi-year deal, to investigate use of wearable sensors in virtual clinical trials. physIQ has a portfolio of FDA-cleared digital biomarkers and a medical-grade platform that can transform raw sensor data into clinical insight.

Licensing 71

Licensing Licensing Trials Clinical Trials 71

Drug Discovery World

APRIL 20, 2023

Dr Paula Moran, Dr Kiri Granger, Dr J Mark Treherne , and Dr Jenny Barnett explore the effects of long Covid-19 symptoms and what the opportunities are for drug developers working to treat post-Covid-19 cognitive impairment. developed dementia over the subsequent two years (vs. Notably, among over-65s who had had Covid-19, 4.5%

Development 98

Development Drugs Clinical Trials Clinical Trials 98

pharmaphorum

FEBRUARY 24, 2022

Hong Kong-based Insilico Medicine has begun a Phase 1 trial of its AI-discovered and AI-designed anti-fibrotic small molecule inhibitor. . These platforms promise to use AI to greatly accelerate the timetable of drug discovery and development, and it’s an area investors are quite bullish on.

Trials 40

Trials Drugs Clinical Trials Clinical Trials 40

Drug Discovery World

JANUARY 24, 2023

Virtual clinical trials ‘Virtual’ and ‘technology’ are concepts which are readily exchanged in this industry, but these are more than just buzzwords. The overall virtual clinical trials market is currently valued at $7.8 billion, with a projected growth of 14% per annum 1. We’ve shown that this type of model can work.

Clinical Trials 97

Clinical Trials Clinical Trials Drugs Trials 97

pharmaphorum

SEPTEMBER 11, 2020

Yet, for clinical trials worldwide, real-time access to data is not the norm – and that lack can create a cascading set of issues affecting every aspect of a study. In a recent analysis, the Tufts Center for the Study for Drug Development reported that more than two-thirds of all sponsors are using at least four different data sources.

Trials 76

Trials Clinical Trials Clinical Trials Pharma Companies 76

pharmaphorum

AUGUST 26, 2021

The pandemic has transformed many aspects of our industry and one area that change has come to is patient engagement within clinical trials, where it would now seem unusual were we to not consider the patient voice when it comes to recruiting trial participants. Boosting clinical trial recruitment with digital marketing.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Marketing 105

pharmaphorum

SEPTEMBER 2, 2020

But many patients still do not respond to therapies such as Merck & Co’s anti PD-1 therapy Keytruda (pembrolizumab), or go on to develop progressive disease, and pharma companies are looking for new second-line therapies. A total of 40 patients are planned to be enrolled.

Trials 108

Trials RNA Pharma Companies Clinical Trials 108

Pharmaceutical Technology

JULY 21, 2022

AI also speeds up the drug development process, which could translate into cheaper drugs for patients. While large pharma companies have been slow in this area, Merck and GSK are now using 3D printing for clinical trials and manufacturing. 3D bioprinting offers an alternative to animal testing in drug development.

FDA Approval 245

FDA Approval Pharma Companies Drugs Clinical Trials 245

World of DTC Marketing

JANUARY 10, 2022

Pharma companies are flush with cash and looking to make deals, but there are still a lot of small biotech companies that don’t have enough money to launch their products entirely. billion, which was much lower than previous studies, which have placed the average cost of drug development as $2.8 million $1228.9

Production 213

Production Drugs Development Marketing 213

World of DTC Marketing

NOVEMBER 27, 2020

Pfizer and Moderna have provided data from their large-scale Phase 3 trials only via news releases , which contained the highly promising news that both vaccines were 90 percent effective or more and have not presented any serious safety concerns. The results of trials were announced in press releases rather than peer-reviewed papers.

Vaccination 208

Vaccination Vaccine Pharma Companies Trials 208

The Pharma Data

DECEMBER 23, 2020

Eligible patients enrolled in the trial receive treatment with AIM’s flagship pipeline drug Ampligen. development pipeline for ME/CFS. The Ampligen EAP protocol is authorized to enroll up to 100 active trial participants, 20 of whom may be Long Haulers. All study subjects will receive the same Ampligen treatments.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Drugs 52

Find Me Cure

SEPTEMBER 2, 2020

As part of our patient advocacy efforts, at FindMeCure we are dedicated to creating a bridge between patients and the world of clinical research. This includes spreading clinical trial awareness, connecting patients to the trials they are interested in but also speaking up about the issues in the clinical research industry. .

Clinical Research 97

Clinical Research Research Clinical Trials Clinical Trials 97

pharmaphorum

JUNE 11, 2021

A digital therapeutic aimed at people with chronic lower back pain based on virtual reality (VR) has shown encouraging results in a clinical trial, helping patients manage the fear of movement that can reduce their activity and impede recovery. So what are the next steps for the development? will be analysed.

Trials 118

Trials Medicine Development Pharma Companies 118